Novelis Inc. Quarterly Costs and Expenses in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Novelis Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q3 2024.
  • Novelis Inc. Costs and Expenses for the quarter ending September 30, 2024 was $4.12B, a 5.54% increase year-over-year.
  • Novelis Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $15.7B, a 3.15% decline year-over-year.
  • Novelis Inc. annual Costs and Expenses for 2023 was $15.4B, a 12.9% decline from 2022.
  • Novelis Inc. annual Costs and Expenses for 2022 was $17.7B, a 11.5% increase from 2021.
  • Novelis Inc. annual Costs and Expenses for 2021 was $15.9B, a 36.9% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $15.7B $4.12B +$216M +5.54% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $15.5B $3.98B +$96M +2.47% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $15.4B $3.85B -$388M -9.15% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-06
Q4 2023 $15.8B $3.76B -$435M -10.4% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $16.2B $3.9B -$651M -14.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $16.9B $3.88B -$814M -17.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $17.7B $4.24B -$387M -8.36% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-06
Q4 2022 $18.1B $4.2B +$217M +5.46% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 $17.9B $4.55B +$749M +19.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $17.1B $4.7B +$1.25B +36.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $15.9B $4.63B +$1.3B +38.9% Jan 1, 2022 Mar 31, 2022 10-K 2024-05-06
Q4 2021 $14.6B $3.98B +$1.01B +34.1% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-06
Q3 2021 $13.5B $3.8B +$1.04B +37.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $12.5B $3.44B +$928M +36.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $11.6B $3.33B +$690M +26.1% Jan 1, 2021 Mar 31, 2021 10-K 2023-05-10
Q4 2020 $10.9B $2.97B +$407M +15.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-07
Q3 2020 $10.5B $2.77B +$83M +3.09% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $10.4B $2.52B -$219M -8.01% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $10.6B $2.64B -$291M -9.92% Jan 1, 2020 Mar 31, 2020 10-K 2022-05-11
Q4 2019 $10.9B $2.56B -$335M -11.6% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-03
Q3 2019 $11.2B $2.68B -$273M -9.24% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $11.5B $2.74B -$172M -5.92% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $11.7B $2.93B +$30M +1.03% Jan 1, 2019 Mar 31, 2019 10-K 2021-05-12
Q4 2018 $11.7B $2.89B +$86M +3.06% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-11
Q3 2018 $11.6B $2.96B +$585M +24.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $11B $2.91B +$382M +15.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $10.6B $2.9B +$370M +14.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-05-07
Q4 2017 $10.2B $2.81B +$606M +27.5% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-05
Q3 2017 $9.63B $2.37B -$52M -2.15% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $9.68B $2.53B +$289M +12.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $9.39B $2.53B +$178M +7.56% Jan 1, 2017 Mar 31, 2017 10-K 2019-05-08
Q4 2016 $9.22B $2.2B -$130M -5.58% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-01
Q3 2016 $9.35B $2.42B -$75M -3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $9.42B $2.24B -$443M -16.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $9.86B $2.36B -$416M -15% Jan 1, 2016 Mar 31, 2016 10-K 2018-05-08
Q4 2015 $10.3B $2.33B -$466M -16.7% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-07
Q3 2015 $10.7B $2.5B -$297M -10.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $11B $2.68B +$58M +2.21% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $11B $2.77B +$261M +10.4% Jan 1, 2015 Mar 31, 2015 10-K 2017-05-10
Q4 2014 $10.7B $2.8B +$405M +16.9% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $10.3B $2.8B +$430M +18.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $9.89B $2.62B +$237M +9.94% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $9.65B $2.51B +$83M +3.42% Jan 1, 2014 Mar 31, 2014 10-K 2016-05-10
Q4 2013 $9.57B $2.39B +$86M +3.73% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $9.48B $2.37B +$11M +0.47% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $9.47B $2.38B -$54M -2.22% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $9.53B $2.43B -$290M -10.7% Jan 1, 2013 Mar 31, 2013 10-K 2013-05-15
Q4 2012 $9.82B $2.31B -$176M -7.09% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-10
Q3 2012 $9.99B $2.35B -$403M -14.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $10.4B $2.44B -$539M -18.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 $10.9B $2.72B -$201M -6.89% Jan 1, 2012 Mar 31, 2012 10-K 2014-05-16
Q4 2011 $11.1B $2.48B -$79M -3.08% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-12
Q3 2011 $11.2B $2.76B +$362M +15.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $10.9B $2.98B +$518M +21.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $10.3B $2.92B Jan 1, 2011 Mar 31, 2011 10-K 2013-05-15
Q4 2010 $2.56B Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-08
Q3 2010 $2.4B Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $2.46B Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.